ultimately isn’t the US where the deeper pool of investors are and with more realistic (read higher) valuations for truly disruptive treatments (thinking more AlphaRET). If the blue sky opportunity comes to pass you’d have to think the US is a better place to get exposure??
ultimately isn’t the US where the deeper pool of investors are...
-
- There are more pages in this discussion • 2,376 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
-0.005(2.27%) |
Mkt cap ! $49.19M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.5¢ | 21.5¢ | $130.0K | 589.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 506631 | 21.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 9070 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| EYE (ASX) Chart |